Atlanta, GA, United States of America

Raul Andreo Gali

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Emory University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Raul Andreo Gali. Retrieved from https://idiyas.com/inventor/raul-andreo-gali

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raul Andreo Gali: Innovator in Neurokinin Receptor Antagonists

Introduction

Raul Andreo Gali is an accomplished inventor based in Atlanta, GA. He has made significant contributions to the field of neuroscience, particularly in the management of conditioned fear. His innovative work focuses on utilizing neurokinin receptor antagonists to address conditions such as Post-Traumatic Stress Disorder (PTSD).

Latest Patents

Gali holds a patent titled "Methods of managing conditioned fear with neurokinin receptor antagonists." This patent relates to methods for managing conditioned fear and conditions induced by experiencing or witnessing extreme traumatic events. The disclosure emphasizes the administration of an effective amount of neurokinin 3 receptor antagonists to individuals diagnosed with PTSD. Gali's work in this area is crucial for developing new therapeutic strategies for those affected by trauma.

Career Highlights

Raul Andreo Gali is affiliated with Emory University, where he conducts research and collaborates with other experts in the field. His dedication to advancing the understanding of neurokinin receptors has positioned him as a key figure in neuroscience research.

Collaborations

Gali works alongside Kerry J Ressler, a prominent figure in the study of PTSD and related conditions. Their collaboration enhances the potential for groundbreaking discoveries in the treatment of trauma-related disorders.

Conclusion

Raul Andreo Gali's innovative work in neurokinin receptor antagonists represents a significant advancement in the management of conditioned fear and PTSD. His contributions to neuroscience continue to pave the way for new therapeutic approaches that can improve the lives of many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…